HUMAN PAPILLOMAVIRUS (HPV)
Clinical trials for HUMAN PAPILLOMAVIRUS (HPV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS (HPV) trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS (HPV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a vaccine plus a Blood-Vessel blocker stop airway growths from coming back?
Disease control Not yet recruitingThis phase II trial tests whether combining bevacizumab, a drug that limits blood vessel growth, with PRGN-2012, a vaccine-based therapy, can help adults with recurrent respiratory papillomatosis (RRP) avoid needing more surgeries. RRP causes wart-like growths in the airway that …
Matched conditions: HUMAN PAPILLOMAVIRUS (HPV)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New study aims to boost cervical cancer screening for women with HIV
Knowledge-focused Not yet recruitingThis study looks at how to make cervical cancer screening easier for women with HIV, who are at higher risk for this cancer. Researchers will talk to patients and doctors to find out what gets in the way of screening and follow-up care. They will also explore using HPV self-testi…
Matched conditions: HUMAN PAPILLOMAVIRUS (HPV)
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
New HPV test could save lives of women with HIV
Knowledge-focused Not yet recruitingThis study looks at better ways to screen for HPV and prevent cervical cancer in women living with HIV. Researchers will test a new method that identifies specific HPV types and viral load. The goal is to see if this approach is practical for a larger future study. About 750 wome…
Matched conditions: HUMAN PAPILLOMAVIRUS (HPV)
Phase: NA • Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC